Skip to main content

Medication Adherence

1
Pipeline Programs
21
Companies
21
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

19 companies ranked by most advanced pipeline stage

BRAND
BRANDGermany - Wertheim
1 program
1
dolutegravir oral tablet 50mgPhase 1
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
6 programs
Adaptive Cell Phone SupportN/A1 trial
Adaptive Cell Phone SupportN/A1 trial
Adaptive Cell Phone SupportN/A1 trial
Cell Phone SupportN/A1 trial
Praise Text MessagesN/A1 trial
+1 more programs
Active Trials
NCT07084155Not Yet Recruiting35Est. Jan 2027
NCT05719064Completed22Est. Feb 2025
NCT07064824Not Yet Recruiting96Est. Jul 2030
+3 more trials
MSD
MSDIreland - Ballydine
3 programs
Comparison to peersN/A
Medication Adherence PartnerN/A
Screening and Brief InterventionN/A
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
3 programs
Comparison to peersN/A1 trial
Medication Adherence PartnerN/A1 trial
Screening and Brief InterventionN/A1 trial
Active Trials
NCT02148523Completed201Est. Jan 2015
NCT02018809Completed200Est. Jan 2015
NCT02604901Completed1,091Est. Jul 2014
Merck & Co.
Merck & Co.RAHWAY, NJ
3 programs
Comparison to peersN/A
Medication Adherence PartnerN/A
Screening and Brief InterventionN/A
Purdue Pharma
Purdue PharmaCT - Stamford
2 programs
Medication reminderN/A1 trial
PatientToc use in pharmaciesN/A1 trial
Active Trials
NCT01755312Terminated28Est. Jan 2015
NCT05235620Unknown1,175Est. Mar 2024
Innovation Pharmaceuticals
2 programs
Medicines optimisationN/A1 trial
SpencerN/A1 trial
Active Trials
NCT03241498Completed356Est. May 2019
NCT04339296Completed91Est. Jul 2020
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Blister packaging medicationsN/A1 trial
Active Trials
NCT01118208Completed303Est. Sep 2014
Veloxis Pharmaceuticals
1 program
Conversion to Envarsus-XR and use of smart phone app, TransMedAxN/A1 trial
Active Trials
NCT04711291Withdrawn0Est. Jul 2023
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Devers Drop DeviceN/A1 trial
Active Trials
NCT03506568Completed50Est. Jun 2021
Prevail Therapeutics
1 program
EMC2N/A1 trial
Active Trials
NCT03652272Completed301Est. Sep 2021
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
EMC2N/A
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
MedViewer reportN/A1 trial
Active Trials
NCT04232540Completed57Est. Nov 2021
Young BioPharma
Young BioPharmaMA - Lowell
1 program
Medication Management ServiceN/A1 trial
Active Trials
NCT06273761Recruiting640Est. May 2027
Alliance Pharmaceuticals
1 program
Screening and Brief InterventionN/A
Catalyst Pharmaceuticals
Catalyst PharmaceuticalsCORAL GABLES, FL
1 program
SpencerN/A
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
caremessageN/A1 trial
Active Trials
NCT03052231Completed80Est. Feb 2017
Impact Therapeutics
Impact TherapeuticsChina - Shanghai
1 program
iTHRIVE 365N/A1 trial
Active Trials
NCT05376397Completed34Est. Nov 2023
Teva
TevaIsrael - Petach Tikva
1 program
Tacrolimus BIDPHASE_3

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Angeles TherapeuticsAdaptive Cell Phone Support
Angeles TherapeuticsAdaptive Cell Phone Support
Young BioPharmaMedication Management Service
Angeles TherapeuticsAdaptive Cell Phone Support
Purdue PharmaPatientToc use in pharmacies
Impact TherapeuticsiTHRIVE 365
Oregon TherapeuticsDevers Drop Device
Angeles TherapeuticsCell Phone Support
Allergy TherapeuticsMedViewer report
Angeles TherapeuticsPraise Text Messages
Innovation PharmaceuticalsSpencer
Prevail TherapeuticsEMC2
Veloxis PharmaceuticalsConversion to Envarsus-XR and use of smart phone app, TransMedAx
Innovation PharmaceuticalsMedicines optimisation
AbbViecaremessage

Showing 15 of 21 trials with date data

Clinical Trials (21)

Total enrollment: 4,967 patients across 21 trials

NCT07064824Angeles TherapeuticsAdaptive Cell Phone Support

Adaptive Cell Phone Support (ACPS)

Start: Aug 2027Est. completion: Jul 203096 patients
N/ANot Yet Recruiting
NCT07084155Angeles TherapeuticsAdaptive Cell Phone Support

Final Prototype Refinement of Adaptive Cell Phone Support

Start: Feb 2026Est. completion: Jan 202735 patients
N/ANot Yet Recruiting
NCT06273761Young BioPharmaMedication Management Service

Evaluation of Medication Management Service

Start: Feb 2024Est. completion: May 2027640 patients
N/ARecruiting
NCT05719064Angeles TherapeuticsAdaptive Cell Phone Support

Early Prototyping and Usability Testing (ACPS)

Start: Jan 2024Est. completion: Feb 202522 patients
N/ACompleted
NCT05235620Purdue PharmaPatientToc use in pharmacies

Evaluation of PatientToc in Community Pharmacies

Start: Jul 2023Est. completion: Mar 20241,175 patients
N/AUnknown
NCT05376397Impact TherapeuticsiTHRIVE 365

Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)

Start: Sep 2021Est. completion: Nov 202334 patients
N/ACompleted
NCT03506568Oregon TherapeuticsDevers Drop Device

A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications

Start: Oct 2020Est. completion: Jun 202150 patients
N/ACompleted
NCT04241627Angeles TherapeuticsCell Phone Support

Cell Phone Support to Promote Medication Adherence Among Adolescents and Young Adults With Chronic Illness

Start: Aug 2020Est. completion: Aug 202234 patients
N/ACompleted
NCT04232540Allergy TherapeuticsMedViewer report

Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)

Start: Jan 2020Est. completion: Nov 202157 patients
N/ACompleted
NCT04995770Angeles TherapeuticsPraise Text Messages

Text Messages for Liver Transplant Recipients

Start: Aug 2019Est. completion: Dec 202035 patients
N/ACompleted
NCT04339296Innovation PharmaceuticalsSpencer

Connected Healthcare for Individuals Living at Home With Chronic Conditions

Start: Mar 2019Est. completion: Jul 202091 patients
N/ACompleted
NCT03652272Prevail TherapeuticsEMC2

Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy

Start: Feb 2019Est. completion: Sep 2021301 patients
N/ACompleted
NCT04711291Veloxis PharmaceuticalsConversion to Envarsus-XR and use of smart phone app, TransMedAx

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

Start: Jun 2017Est. completion: Jul 20230
N/AWithdrawn
NCT03241498Innovation PharmaceuticalsMedicines optimisation

General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation

Start: Dec 2016Est. completion: May 2019356 patients
N/ACompleted
NCT03052231AbbViecaremessage

Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center

Start: Mar 2016Est. completion: Feb 201780 patients
N/ACompleted
NCT02018809Sharp TherapeuticsMedication Adherence Partner

Social Forces to Improve Statin Adherence (Study A)

Start: Jan 2014Est. completion: Jan 2015200 patients
N/ACompleted
NCT02148523Sharp TherapeuticsComparison to peers

Social Forces to Improve Statin Adherence (Study B)

Start: Jan 2014Est. completion: Jan 2015201 patients
N/ACompleted
NCT01755312Purdue PharmaMedication reminder

The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes

Start: Jun 2013Est. completion: Jan 201528 patients
N/ATerminated
NCT02604901Sharp TherapeuticsScreening and Brief Intervention

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications

Start: Jun 2012Est. completion: Jul 20141,091 patients
N/ACompleted
NCT01118208Colorado TherapeuticsBlister packaging medications

Blister Packaging Medication to Increase Treatment Adherence and Clinical Response

Start: Sep 2009Est. completion: Sep 2014303 patients
N/ACompleted
NCT02827773Angeles TherapeuticsTalking Pill Bottle

Improving Medication Adherence: A Study With Talking Pill Bottles

Start: Mar 2009Est. completion: Oct 2010138 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 4,967 patients
21 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.